FDA warns Eye­Point over eye im­plant man­u­fac­tur­ing woes

The FDA has sent Eye­Point Phar­ma­ceu­ti­cals a warn­ing let­ter af­ter un­cov­er­ing man­u­fac­tur­ing is­sues with the com­pa­ny’s eye im­plant Yu­tiq.

The let­ter, is­sued Ju­ly 12 and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER